OLMISTRUM MT 25

Avoid or limit alcohol while taking Olmesartan Medoxomil and Metoprolol Succinate, as alcohol may increase the blood pressure-lowering effect of this medicine and cause dizziness, light-headedness, or fainting. Consult your doctor about whether alcohol is safe for you during treatment.

Olmesartan Medoxomil and Metoprolol Succinate should be reviewed carefully during pregnancy. Olmesartan can harm an unborn baby, particularly during the second and third trimesters, and should be discontinued promptly under medical guidance if pregnancy occurs. Inform your doctor if you are pregnant, planning pregnancy, or suspect you may be pregnant so that a suitable alternative can be considered.

If you are breastfeeding, consult your doctor before taking Olmesartan Medoxomil and Metoprolol Succinate. Information about olmesartan use during breastfeeding is limited, and metoprolol may pass into breast milk. Your doctor will assess the benefits of treatment and breastfeeding, consider suitable alternatives if needed, and advise whether your baby requires monitoring.

Olmesartan Medoxomil and Metoprolol Succinate may cause dizziness, tiredness, light-headedness, or weakness, especially when treatment begins or the dose changes. These effects can affect concentration and reaction time. Avoid driving, cycling in traffic, or operating machinery if you experience these symptoms. Resume such activities only when you feel alert and safe.

Patients with kidney problems should use Olmesartan Medoxomil and Metoprolol Succinate under medical supervision. Olmesartan may affect kidney function in some patients, particularly those who are dehydrated or have existing kidney disease. Your doctor may monitor kidney function, blood pressure, and potassium levels and adjust treatment according to your condition. Do not change the dose yourself.

Inform your doctor if you have liver disease before taking Olmesartan Medoxomil and Metoprolol Succinate. Liver impairment may affect how the body handles components of this medicine, particularly metoprolol. Your healthcare professional may recommend closer monitoring or a dose adjustment based on your liver function and overall health. Report unusual symptoms such as yellowing of the skin or eyes promptly.